Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria offers a strong 10.4% net payout yield. The NPY isn't the largest around, but the amount is very impressive for a company not increasing debt to repurchase shares.

Altria: This Net Payout Yield Tops Others

Best Buy

Biogen

Capital One

Dollar General

eBay

Intel

Liberty Global Ltd

Lowe's

Lumen Technologies

LyondellBasell Industries

Oracle

Regeneron Pharmaceuticals

Sirius XM Holdings Inc

Seagate Technology Holdings PLC

Synchrony Financial

Vodafone Group

The top net payout yield stock failed to match the total return of the S&P 500 during 2H '22 as tech stocks soared. The top net payout yield stocks averaged massive 19.6% yields to start December, as normal capital return plans returned during 2022.

Top Net Payout Yields - December 2022

Broadcom

Bristol-Myers

Costco

Johnson & Johnson

Microsoft

QUALCOMM

Raytheon Technologies

Verizon

These high-quality dividend stocks could outperform the market in 2023

10 Top Dividend Stocks To Buy For 2023

If you believe in the safety of the Altria Group, Inc. dividend, reinvesting at lows is a no-brainer. While Altria is held for its dividend, it does not necessarily mean everyone holding it is a retiree.

Altria: Why I Continue Reinvesting

Cronos Group

Altria Group Inc, through its subsidiary Altria Summit LLC, has relinquished a warrant to buy more shares in Cronos Group Inc (NASDAQ:CRON, TSX:CRON) sending shares in the Canadian cannabis company, 5.9% lower. In March 2019, Altria acquired, through its subsidiaries, a 45% stake in Cronos plus the warrant which was exercisable until March 8, 2023, at a price of C$19.00 per share.

Altria Group relinquishes warrant which could have led to increased stake in Cronos Group

Altria Group Inc. MO, -0.83% said Monday it will continue to evaluate prospects of cannabis company Cronos Group Inc. CRON, +1.79% on whether it will acquire additional common shares of Cronos or dispose of them in the open market, in privately negotiated transactions with Cronos or third parties. Altria expects to claim a capital loss of $483 million on its U.S federal consolidated income tax return for 2022, related to its stake in Cronos Group.

Altria to claim $483 mln capital loss on cannabis company ownership stake

RICHMOND, Va.--( BUSINESS WIRE )--Altria Group, Inc (NYSE:MO) today announced that its wholly owned subsidiary, Altria Summit LLC, has notified Cronos Group Inc. (Cronos) of its irrevocable abandonment of (i) its warrant to purchase additional common shares of Cronos (the Warrant) and (ii) all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration.

Altria Abandons Expiring Cronos Warrant; Maintains Initial Investment

Altria Group has outperformed the market in 2022 and provides a high-yield for income investors. Even with the outperformance in 2022, shares of MO still look intriguing at current levels heading into a rough 2023 economic period.

Altria: A Great High-Yield Option For The Coming Recession

British American Tobacco

Philip Morris

With their total returns being impressively better than the broader market this year, investors might want to consider these equities for 2023 as well.

Should Investors Buy Big Tobacco Stocks?

BlackRock Science & Technology

New York Community Bancorp

Owl Rock Capital Corp

abrdn World Healthcare Fund 

Global X S&P 500 Covered Call ETF

The Dividend Harvesting Portfolio is now generating $703.25 in annual dividends, yielding 7.73%. The Dividend Harvesting portfolio has a 76.34% record of finishing the week in the black since its inception, 71/93 weeks.

Dividend Harvesting Portfolio Week 93 Update: $9,300 Allocated, $703.25 In Projected Annual Dividends

Periods of elevated inflation tend to see high-yield stocks outperform. Altria Group is one of the best stocks of 2022, and its rally could extend into 2023 and beyond. Since bottoming during the Pandemic, Altria Group has delivered 20% annual returns, just as it had for 90 years when it was the best stock in history.

Altria: Buy This 8% Yielding Dividend Aristocrat Before The Yield Goes To 10.5%

Energy Transfer LP Unit

ONEOK

Rio Tinto plc Sponsored

Simon Property Group

While it is becoming clear that inflation is dropping, November's consumer price index came in up 7.1% year over year (versus expectations for 7.3%), the reality is that costs for essential items like food remain very high.

Sell the Rally Now and Grab These 7 ‘Strong Buy' 5% and Higher 2023 Dividend Winners

Apple

Bank of America

Blackrock Inc

NIKE

Realty Income Corp

Unilever

Visa

Exxon Mobil

Imagine that you will invest $10,000 and you aim to combine Dividend Income with Dividend Growth. I will demonstrate how you could reach a balanced mix between Dividend Income and Dividend Growth when building an investment portfolio.

How To Allocate $10,000 Among 10 Dividend Income And Dividend Growth Stocks

Kraft Heinz

Are these the top dividend stocks to watch in the stock market today?

3 Dividend Stocks To Watch In The Stock Market Today

Clorox

Gap Inc

Hanesbrands

Macerich

Scotts Miracle-Gro

ZIM Integrated Shipping Services

The economy is either already in recession or it is likely to be in one in 2023. As a result, some dividend stocks are worth buying for investors.

7 Dividend Stocks to Sell Before They Dive in 2023

Chevron

Kimberly-Clark

McDonald's

Procter & Gamble

Public Storage

V.F.

The top dividend stock picks for 2023 are surefire ways for investors to protect themselves against several current issues. Their dividends provide extra returns for portfolios that have been battered in a very difficult 2022.

Our 7 Top Dividend Stock Picks for 2023

Altria and Dollar General could be great buys in this uncertain economic climate.

Got $1,000? 2 Value Stocks to Buy Right Now

Juul Labs Inc. has agreed to pay $1.7 billion in a broad legal settlement covering more than 5,000 lawsuits, according to people familiar with the matter.

Juul to pay $1.7 billion in legal settlement involving more than 5,000 lawsuits

The settlement announced earlier this week covers more than 5,000 lawsuits and involves allegations the e-cigarette maker marketed to children and teens.

Juul to Pay $1.7 Billion in Legal Settlement

News for Altria Stock (MO)